Colleen Moretti

The best advocate for a patient with cancer is someone who knows exactly what they're going through, noted a multiple myeloma survivor.

As part of its Heal at Home series, CURE® collaborated with a clinical health psychologist at the University of Hawaii Cancer Center to provide cancer survivors an easy-to-understand guide to start meditating.

Although much has changed in the past two decades, more needs to be done to prepare cancer survivors for what happens after their treatments end.

Unreliable public transportation or limited access to a working vehicle may lead to delays in important follow-up care for cancer survivors.

Watch Dr. Umang Swami, from Huntsman Cancer Institute, discuss genomic changes and PARP inhibitors, during the CURE Educated Patient Prostate Cancer Summit.

Watch Dr. Veda N. Giri, from Sidney Kimmel Cancer Center at Thomas Jefferson University, discuss genetic testing and who should get it, during the CURE Educated Patient Prostate Cancer Summit.

Although ineffective in patients with non-small cell lung cancer and brain metastases at diagnosis, treatment with Exkivity may benefit patients with EGFR exon 20 insertion-positive metastatic disease.

Actress and comedian Jessica St. Clair and her husband, Dan O’Brien, share their roles of partner and parent, but also patient and cancer caregiver, as their roles were reversed in the blink of an eye.

Adding Imbruvica to a standard-of-care chemotherapy-immunotherapy treatment regimen was associated with a significant improvement in survival in older patients with newly diagnosed mantle cell lymphoma.

A small percentage of patients with metastatic breast cancer participating in clinical trials in the U.S. are Black, which, according to a patient living with the disease is a huge concern since it doesn’t represent the general population.

The combination of Tibsovo and Vidaza improved progression-free survival and overall survival and presented a favorable safety profile for older patients with acute myeloid leukemia.

Watch Kapila Viges, from the MPN Research Foundation, discuss clinical trials, during the CURE Educated Patient MPN Summit.

Watch Dr. Angela Fleishman, from the University of California Irvine, discuss novel agents and clinical trials in polycythemia vera, during the CURE Educated Patient MPN Summit.

The FDA’s approval of Enhertu in this setting, according to an expert, marks an important milestone and will allow patients with unresectable or metastatic HER2-positive breast cancer to be treated in an earlier line, with the possibility of delaying disease progression.

Unrelieved stress may play a part in causing cancer-related cognitive impairment and anxiety, though more research is needed.

While a higher risk of heart issues was found in older men years after androgen-deprivation therapy, it is unknown if the risk comes from the treatment or other age-related comorbidities.

Cognitive behavioral therapy has been proven to improve insomnia in cancer survivors, but research is lacking in patients who are currently undergoing treatment or who have advanced disease.

Imfinzi alone is the standard of care in this patient population, however two combinations may have better outcomes.

Alex Mallonee has found it inspiring to depict his mother’s journey with breast cancer through art, and hopes others affected by cancer will feel the same.

Treatment with a combination of Ofev and chemotherapy was shown to have a survival benefit in a group of patients with bladder cancer.

Watch Dr. Jose Karam, from The University of Texas MD Anderson Cancer Center, discuss surgical options, during the CURE Educated Patient Kidney Cancer Summit.

An expert noted that despite the results, all patients with cancer should be aware of their increased risk for developing blood clots.

Patients with early-stage breast cancer are advised to ask their provider what the least invasive treatment option is available to them that gives them both a great cure rate and a much better quality of life.

Watch Dr. Vitaly Margulis, from UT Southwestern Medical Center, discuss staging, during the CURE Educated Patient Kidney Cancer Summit.

Patients with myeloproliferative neoplasms, a group of blood cancers, who plan to conceive should talk with their doctor about their obstetric and medical history and risk of complications, according to an expert.

Patients who are part of an advocacy group may be better equipped to understand biomarker testing during a lung cancer diagnosis and feel more empowered.

The FDA’s recent approval of Opdivo plus chemotherapy may be beneficial for some patients with non-small cell lung cancer, further highlighting the need for multidisciplinary care.

“It’s important for patients to be educated on (next-generation sequencing), because the more we know about a patient’s cancer, the better we can design a personalized treatment plan,” says an expert.

Monumental treatment advancements over the past two decades have given patients with thyroid cancer the ability to live longer and better lives, according to an expert from Cleveland Clinic’s Taussig Cancer Institute. However, more work is needed to find curative treatments.

Watch Dr. Carlyn Rose Tan, an assistant attending in myeloma service at Memorial Sloan Kettering Cancer Center, present on risk stratification for newly diagnosed patients.